Business Segments · Other long-lived assets

Reportable Segment — Other long-lived assets

Biogen Reportable Segment — Other long-lived assets decreased by 6.1% to $3.32B in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ4 2025
Rolls up toPP&E (Net)

How to read this metric

An increase suggests capital investment in infrastructure or acquisitions, while a decrease may indicate depreciation or asset divestitures.

Detailed definition

This metric measures the book value of non-current assets held by the segment, including property, plant, equipment, and...

Peer comparison

Standard 'Long-Lived Assets' or 'Non-Current Assets' reported by capital-intensive firms.

Metric ID: biib_segment_reportable_segment_other_long_lived_assets

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$3.70B$3.73B$3.54B$3.32B
QoQ Change+0.7%-5.1%-6.1%
YoY Change+0.7%-5.1%-6.1%
Range$3.32B$3.73B
Avg YoY Growth-3.5%
Median YoY Growth-5.1%
Current Streak2 quarters decline

Frequently Asked Questions

What is Biogen's reportable segment — other long-lived assets?
Biogen (BIIB) reported reportable segment — other long-lived assets of $3.32B in Q4 2025.
What does reportable segment — other long-lived assets mean?
The total value of long-term physical and intangible assets owned by the business segment.